Form 4: Pluri Director & 10% Owner Boosts Stake via Warrant Exercises

Alexandre Weinstein, a director and 10% owner of Pluri Inc., significantly increased his indirect beneficial ownership through the exercise of pre-funded warrants and acquisition of common stock.

Summary

• Alexandre Weinstein, a director and 10% owner of Pluri Inc., reported several transactions increasing his beneficial ownership.
• On October 29, 2025, 1,002,169 pre-funded warrants were exercised at a conversion price of $0.0001, resulting in the acquisition of 1,002,169 common shares. These warrants became exercisable after the company's shareholders meeting on June 30, 2025.
• The exercised pre-funded warrants comprised 26,030 warrants from a January 23, 2025 private placement and an additional 976,139 warrants issued on April 25, 2025, under an amendment to a Securities Purchase Agreement.
• On April 28, 2025, 452,702 common shares were acquired indirectly through Plantae Bioscience Ltd. at a price of $4.61 per share. Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd.
• On February 25, 2025, 10,250 common shares were acquired directly by Mr. Weinstein at a price of $0.00.
• Following these reported transactions, Mr. Weinstein's indirect beneficial ownership through Chutzpah Holdings Limited is 1,933,415 common shares, and 452,702 common shares through Plantae Bioscience Ltd.
• Chutzpah Holdings Limited also acquired 84,599 common warrants on January 23, 2025, with an exercise price of $5.568, as part of a private placement. These common warrants are exercisable until June 30, 2028.
• An inadvertently omitted transaction from January 1, 2025, was discovered on October 31, 2025, and is now being reported.

Sentiment

Score: 7

Explanation: The significant increase in insider ownership through warrant exercises and share purchases is a positive signal of confidence, despite a minor reporting delay.

Positives

• A director and 10% owner, Alexandre Weinstein, significantly increased his beneficial ownership in Pluri Inc. through warrant exercises and share acquisitions, indicating strong confidence in the company's future.
• The exercise of 1,002,169 pre-funded warrants at a nominal price of $0.0001 converts derivative securities into common stock, solidifying the insider's direct equity stake.
• The acquisition of 452,702 common shares at $4.61 through Plantae Bioscience Ltd. represents a substantial investment at a market-related price.

Negatives

• The filing indicates an inadvertently omitted transaction from January 1, 2025, which was only discovered and reported on October 31, 2025, suggesting a lapse in timely SEC reporting compliance.

Risks

• The reporting person disclaims beneficial ownership of securities owned by Plantae Bioscience Ltd. except to the extent of his pecuniary interest, which could imply a nuanced ownership structure and potential limitations on control.
• The inadvertent omission of a prior transaction could raise questions about the effectiveness of internal compliance procedures for SEC reporting.

Future Outlook

N/A

Industry Context

This Form 4 filing reflects an insider's increased stake in Pluri Inc., a common occurrence in the biotech or pharmaceutical industry where long-term commitment from key individuals can signal confidence in future pipeline developments or strategic direction. While not directly tied to broader industry trends, significant insider buying can be viewed positively by the market.

Related Party Transactions

• Transactions involve Chutzpah Holdings Limited, which Mr. Weinstein indirectly owns 100%.
• Transactions involve Plantae Bioscience Ltd., which Mr. Weinstein indirectly owns 77%.

Stakeholder Impact

• Shareholders: Increased insider ownership may be viewed as a positive signal of confidence, potentially boosting investor sentiment.
• Management: The reporting person is a director and 10% owner, aligning his interests further with the company's performance.

Key Dates

Recommendation

While the significant insider buying by a director and 10% owner is a positive indicator of confidence, the nature of the transactions (warrant exercises and private placement acquisitions) means the insider is largely converting existing rights or participating in structured offerings rather than making open market purchases at prevailing prices. This signals commitment but doesn't necessarily imply an immediate undervaluation. The reporting delay for an earlier transaction is a minor compliance concern. Therefore, a 'hold' recommendation is appropriate, suggesting investors monitor future developments and broader company performance.

Keywords

Pluri Inc., PLUR, Form 4, Insider Trading, Alexandre Weinstein, Chutzpah Holdings, Plantae Bioscience, Warrant Exercise, Common Stock Acquisition, 10% Owner, Director, Private Placement, Beneficial Ownership